Ireland
--:--IST
Active, not recruiting Not applicable

Intraprostatic Anesthesia During Transperineal Prostate Biopsy

NCT07683182 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-11-01
Last updated
2026-07-06

Condition(s) studied

Prostate Cancer (Diagnosis)Prostate-Specific Antigen

Investigational drug(s) / intervention(s)

Prilocaine →Bupivacaine →Perineal Local AnesthesiaIntraprostatic Local AnesthesiaTransperineal Prostate BiopsyTransrectal Ultrasound (TRUS) System

Prilocaine: Prilocaine is used as part of the local anesthetic mixture administered for perineal local anesthesia in both groups and for intraprostatic local anesthesia in the experimental group.

Bupivacaine: Bupivacaine is used as part of the local anesthetic mixture administered for perineal local anesthesia in both groups and for intraprostatic local anesthesia in the experimental group.

Perineal Local Anesthesia: Participants receive perineal local anesthesia consisting of infiltration of the perineal skin and subcutaneous tissues using a mixture of 5 mL prilocaine, 5 mL bupivacaine, and 10 mL normal saline before transperineal prostate biopsy.

Intraprostatic Local Anesthesia: Participants receive intraprostatic local anesthesia consisting of 5 mL of the same anesthetic mixture administered equally to both prostatic lobes during transperineal prostate biopsy.

Transperineal Prostate Biopsy: Participants undergo standard transperineal prostate biopsy under local anesthesia according to the institutional biopsy protocol.

Transrectal Ultrasound (TRUS) System: A transrectal ultrasound (TRUS) system is used to provide real-time ultrasound guidance during transperineal prostate biopsy. The TRUS probe is inserted into the rectum to visualize the prostate and guide accurate needle placement through the perineum for systematic prostate biopsy under local anesthesia. The device is used in both study groups.

Study summary

Transperineal prostate biopsy has become the standard method for diagnosing prostate cancer because of its favorable safety profile and low infectious complication rates. However, pain and discomfort during the procedure remain important concerns that may negatively affect patient satisfaction and willingness to undergo repeat biopsy when necessary.

This prospective randomized controlled study aims to evaluate whether the addition of intraprostatic local anesthesia to standard perineal local anesthesia reduces pain during transperineal prostate biopsy. Fifty patients undergoing prostate biopsy under local anesthesia will be randomized into two groups. The first group will receive standard perineal local anesthesia, while the second group will receive additional intraprostatic local anesthesia.

Pain severity will be assessed before, during, and after the procedure using a visual analog scale (VAS). Anxiety and depression levels will be evaluated preoperatively using the Hospital Anxiety and Depression Scale (HADS). Patient-related factors, procedural characteristics, and post-procedural outcomes will also be recorded to identify factors associated with pain perception.

The results of this study may help optimize local anesthesia techniques and improve patient comfort during transperineal prostate biopsy.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male patients aged 18 years or older * Clinical indication for transperineal prostate biopsy based on elevated prostate-specific antigen (PSA) level and/or suspicious digital rectal examination findings * Ability to understand and complete the Hospital Anxiety and Depression Scale (HADS) * Ability to provide pain scores using a 10-point Visual Analog Scale (VAS) * Provision of written informed consent Exclusion Criteria: * Previous history of prostate biopsy * Known hypersensitivity or contraindication to local anesthetic agents * Hematological disorders affecting coagulation * Active urinary tract infection * Neurological disorders that may affect pain perception * Psychiatric disorders that may affect pain assessment or completion of study -questionnaires * Inability to complete the HADS questionnaire or VAS assessment * Refusal to participate or inability to provide informed consent

Primary outcome measure(s)

  • Pain During Transperineal Prostate Biopsy — During the biopsy procedure
    Pain severity during transperineal prostate biopsy will be assessed using the Visual Analog Scale (VAS), a patient-reported pain scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores indicate greater pain severity. Pain scores will be compared between participants receiving perineal local anesthesia alone and those receiving additional intraprostatic local anesthesia.

Trial sites (1)

FacilityCityRegionStatus
Marmara University School of Medicine Istanbul Pendik
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07683182 on ClinicalTrials.gov ↗ ← All trials in Turkey